Longitudinal assessment of SARS-CoV-2-specific T Cell cytokine-producing responses for 1 year Reveals persistence of multicytokine proliferative responses, with greater immunity associated with disease severity

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1128/jvi.00509-22
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: ; Search for: 1ORCID identifier: https://orcid.org/0000-0001-7934-4866; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ORCID identifier: https://orcid.org/0000-0002-7369-1936
EditorSearch for: Heise, Mark T.
Affiliation
  1. National Research Council Canada. Digital Technologies
FunderSearch for: Gouvernement du Canada | Canadian Institutes of Health Research; Search for: Ontario HIV Treatment Network
FormatText, Article
SubjectELISpot assay; SARS-CoV-2; T cell immunity; cytokines; granzyme B; immune modeling
Abstract
Publication date
PublisherAmerican Society for Microbiology
In
LanguageEnglish
Peer reviewedYes
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier59103c22-1dda-4057-a5c4-ec8f1bb76713
Record created2022-07-11
Record modified2022-10-19
Date modified: